Test Guide Mobile Home
Search: Search

Androstenedione


Serum
Test performed by: LabPLUS High Performance Liquid Chromatography


SST and Heparin tubes are no longer suitable tube types for this assay


Specimen Collection

This test may be vetted by a pathologist.

The clinical information for the test must be clearly written on the request form. If clinical information is not provided, or does not provide sufficient justification for the test, the test may be declined.

Declined tests :

If a test is declined, the specimen will be held for a reasonable period (usually 3 weeks but dependant on the stability of the sample). Medical practitioners seeking approval for a declined test should email the on-call Chemical Pathologist ( chemicalpathologist@adhb.govt.nz ) , giving the patient's name and NHI number and the clinical justification for the test. If unable to email, call the on-call Chemical Pathologist via Lablink (09-3078995) and identify yourself as a doctor.

Test vetting policy


Plain

4 mL Plain Blood (Preferred)

EDTA

4 mL EDTA Blood

Microsample

0.5 mL Paediatric Microsample Blood

Micro-EDTA

0.5 mL Paediatric Micro-EDTA Blood
Reference Intervals

Units: nmol/L

AGE

Androstenedione (nmol/L)

0 to 3 months

0 - 6

3 months to 10 years (prepubertal)

0 - 2

Puberty

Post-pubertal and adults (male and female)

Levels rise through puberty

0 - 8

Uncertainty of Measurement: 26% at 1.8 nmol/L

18% at 9 nmol/L

15% at 25 nmol/L

References:

1. Kushnir, M. M., T. Blamires, et al. (2010). "Liquid chromatography-tandem mass spectrometry assay for androstenedione, dehydroepiandrosterone, and testosterone with pediatric and adult reference intervals." Clin Chem 56 (7): 1138-1147.

2. Kyriakopoulou, L., M. Yazdanpanah, et al. (2013). "A sensitive and rapid mass spectrometric method for the simultaneous measurement of eight steroid hormones and CALIPER pediatric reference intervals." Clin Biochem 46 (7-8): 642-651.

3. Rauh, M., M. Groschl, et al. (2006). "Automated, fast and sensitive quantification of 17 alpha-hydroxy-progesterone, androstenedione and testosterone by tandem mass spectrometry with on-line extraction." Steroids 71 (6): 450-458.

4. Kulle, A. E., F. G. Riepe, et al. (2010). "A novel ultrapressure liquid chromatography tandem mass spectrometry method for the simultaneous determination of androstenedione, testosterone, and dihydrotestosterone in pediatric blood samples: age- and sex-specific reference data." J Clin Endocrinol Metab 95 (5): 2399-2409.

5. Keefe, C. C., M. M. Goldman, et al. (2014). "Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry." PLoS One 9 (4): e93805.

6. Fanelli, F., A. Gambineri, et al. (2013). "Androgen profiling by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in healthy normal-weight ovulatory and anovulatory late adolescent and young women." J Clin Endocrinol Metab 98 (7): 3058-3067.



Turnaround Time: Within 1 week

Only available 0800 - 1700 weekdays.


Assay Method

Principle : Tandem mass spectrometry

Assay : In-house

Analyser : Shimadzu LC-MS/MS


Diagnostic Use and Interpretation

Androstenedione is a testosterone precursor which is secreted by both ovary and adrenal glands.

Although androstenedione is commonly elevated in PCOS and idiopathic hyperandrogenism, its measurement adds no diagnostic value over testosterone in these conditions.

Its diagnostic use is in the diagnosis and monitoring of congenital adrenal hyperplasia , and androgen secreting tumours of ovary and adrenal .


Androstenedione requests are subject to pathologist approval.

Androstenedione requests are likely to be declined if the testosterone level is normal. Please provide a clinical rationale for the test on the request form.


References

1. Martin, K. A., R. J. Chang, et al. (2008). "Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline." J Clin Endocrinol Metab 93(4): 1105-1120.

2. Legro, R. S., S. A. Arslanian, et al. (2013). "Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline." J Clin Endocrinol Metab 98 (12): 4565-4592.





Contact Information

Emails to chemicalpathologist@adhb.govt.nz will receive priority attention from the on-call chemical pathologist.

If the query concerns a specific patient please include the NHI number in your email.

If email is not a suitable option, please contact the on-call chemical pathologist via Lablink (Auckland City Hospital ext. 22000 or 09-3078995).

Individual chemical pathologists may be contacted but will not be available at all times.

After-hours : contact Lablink (Auckland City Hospital ext. 22000 or 09-3078995) or hospital operator for on duty staff after hours.


Dr Samarina Musaad (Clinical Lead) : SamarinaM@adhb.govt.nz ext. 22402

Dr Cam Kyle: CampbellK@adhb.govt.nz ext 22052

Dr Weldon Chiu: WeldonC@adhb.govt.nz ext. 23427

Dr Campbell Heron: CHeron@adhb.govt.nz ext. 23427

Dr Sakunthala Jayasinghe: Sakunthala@adhb.govt.nz ext. 23427



Specimen Transport Instructions for Referring Laboratories

Sample

Serum - Plain

EDTA plasma

(SST and Heparin tubes are NOT suitable)

Sample Preparation

Centrifuge and aliquot - 500uL

Freeze

Sample Stability

Room temperature up to 24 hours

Refrigerated up to 4 days

Freeze if more than 4 days

Transport to LabPlus

Send refrigerated up to 4 days

Send frozen if more than 4 days

Reference:

1. Griffith C, Owen L, Keevil B. (2008). Stability of testosterone and androstenedione in refrigerated serum samples. Annals Clin Biochem 45 (Suppl 1): 107



Last updated at 15:26:00 06/01/2025